Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
2(50%)
Results Posted
100%(2 trials)

Phase Distribution

Ph phase_3
1
25%
Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(2)

Detailed Status

Recruiting2
Completed2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (25.0%)
N/A3 (75.0%)

Trials by Status

recruiting250%
completed250%

Recent Activity

2 active trials
Showing 4 of 4
recruitingnot_applicable

Cervical Ripening Balloons for Same-Day Cervical Prep

NCT06964373
recruitingnot_applicable

RCT of Cervical Ripening Double Ballon Catheter Prior to Dilation and Evacuation.

NCT07200115
completedphase_3

Mifepristone Versus Osmotic Dilator Insertion for Cervical Preparation Prior to Surgical Abortion at 15-18 Weeks

NCT01436279
completednot_applicable

Cervical Preparation Before Dilation and Evacuation

NCT01751087

Clinical Trials (4)

Showing 4 of 4 trials
NCT06964373Not Applicable

Cervical Ripening Balloons for Same-Day Cervical Prep

Recruiting
NCT07200115Not Applicable

RCT of Cervical Ripening Double Ballon Catheter Prior to Dilation and Evacuation.

Recruiting
NCT01436279Phase 3

Mifepristone Versus Osmotic Dilator Insertion for Cervical Preparation Prior to Surgical Abortion at 15-18 Weeks

Completed
NCT01751087Not Applicable

Cervical Preparation Before Dilation and Evacuation

Completed

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4